AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Dermatology Conference Highlights Gene Expression Tests for Skin Cancer
From - Diagnostic Testing & Emerging Technologies
Several companies presented findings at the American Academy of Dermatology's annual meeting (Feb. 16-18, San Diego) indicating that…
Out of Network: 6 Frequently Asked Questions
By Richa Singh bio
As labs face an increasingly challenging reimbursement environment, more providers are doubling down on out-of-network strategies to maximize on collections opportunities…
Genotype-Matched Diets Don’t Aid Weight Loss
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Next-Gen Sequencing, AI Driving Investor Interest in Diagnostics Sector
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades
By Jeff Myers bio
Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture intelligence on…
FDA Set Record in 2017 for Targeted Therapy Approvals
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Speed Record Set for Whole-Genome Sequencing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…
FDA Approves First Objective Blood Test for Concussion Evaluation
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first blood test to evaluate concussions in adults…
Study Shows Progress Towards a Blood-Based, Multi-Cancer Screen
From - Diagnostic Testing & Emerging Technologies
A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published…
